Cargando…

Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital

OBJECTIVE: To detect incidence of adverse drug reactions (ADRs) in hospitalized patients and to assess their causality, seriousness, preventability, and the possible economic impact. MATERIALS AND METHODS: This was a prospective study carried out in two medical units at a tertiary care, teaching hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Doshi, Maulik S., Patel, Prakruti P., Shah, Samidh P., Dikshit, Ram K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543550/
https://www.ncbi.nlm.nih.gov/pubmed/23326101
http://dx.doi.org/10.4103/0976-500X.103687
_version_ 1782255676269002752
author Doshi, Maulik S.
Patel, Prakruti P.
Shah, Samidh P.
Dikshit, Ram K
author_facet Doshi, Maulik S.
Patel, Prakruti P.
Shah, Samidh P.
Dikshit, Ram K
author_sort Doshi, Maulik S.
collection PubMed
description OBJECTIVE: To detect incidence of adverse drug reactions (ADRs) in hospitalized patients and to assess their causality, seriousness, preventability, and the possible economic impact. MATERIALS AND METHODS: This was a prospective study carried out in two medical units at a tertiary care, teaching hospital, for about 18 months. All the admitted patients who developed an ADR after admission (group A) or who were admitted primarily for the treatment of an ADR (group B) were included. Descriptive statistics with 95% CI, χ(2), χ(2) for the trend and kappa test were used. RESULTS: Out of 6601 patients, 140 patients developed 154 ADRs with an incidence of 2.12%. Causality of the majority of the ADRs in group A was ‘possible’ while those in group B was ‘probable’. Among 109 ADRs (34 serious) in group A, 38 were preventable. On the other hand, out of 45 serious ADRs in group B, 19 were preventable. The total cost of 154 ADRs in 140 patients was Rs. 1,49,803 with an average of Rs. 1070 per patient. The preventable cost for 57/154 ADR was Rs. 96,310. CONCLUSION: Around 2% of the hospital patients develop ADRs. A large number of these ADRs were preventable. A substantial saving can be made if adequate caution is exerted.
format Online
Article
Text
id pubmed-3543550
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35435502013-01-16 Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital Doshi, Maulik S. Patel, Prakruti P. Shah, Samidh P. Dikshit, Ram K J Pharmacol Pharmacother Research Paper OBJECTIVE: To detect incidence of adverse drug reactions (ADRs) in hospitalized patients and to assess their causality, seriousness, preventability, and the possible economic impact. MATERIALS AND METHODS: This was a prospective study carried out in two medical units at a tertiary care, teaching hospital, for about 18 months. All the admitted patients who developed an ADR after admission (group A) or who were admitted primarily for the treatment of an ADR (group B) were included. Descriptive statistics with 95% CI, χ(2), χ(2) for the trend and kappa test were used. RESULTS: Out of 6601 patients, 140 patients developed 154 ADRs with an incidence of 2.12%. Causality of the majority of the ADRs in group A was ‘possible’ while those in group B was ‘probable’. Among 109 ADRs (34 serious) in group A, 38 were preventable. On the other hand, out of 45 serious ADRs in group B, 19 were preventable. The total cost of 154 ADRs in 140 patients was Rs. 1,49,803 with an average of Rs. 1070 per patient. The preventable cost for 57/154 ADR was Rs. 96,310. CONCLUSION: Around 2% of the hospital patients develop ADRs. A large number of these ADRs were preventable. A substantial saving can be made if adequate caution is exerted. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3543550/ /pubmed/23326101 http://dx.doi.org/10.4103/0976-500X.103687 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Doshi, Maulik S.
Patel, Prakruti P.
Shah, Samidh P.
Dikshit, Ram K
Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
title Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
title_full Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
title_fullStr Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
title_full_unstemmed Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
title_short Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
title_sort intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543550/
https://www.ncbi.nlm.nih.gov/pubmed/23326101
http://dx.doi.org/10.4103/0976-500X.103687
work_keys_str_mv AT doshimauliks intensivemonitoringofadversedrugreactionsinhospitalizedpatientsoftwomedicalunitsatatertiarycareteachinghospital
AT patelprakrutip intensivemonitoringofadversedrugreactionsinhospitalizedpatientsoftwomedicalunitsatatertiarycareteachinghospital
AT shahsamidhp intensivemonitoringofadversedrugreactionsinhospitalizedpatientsoftwomedicalunitsatatertiarycareteachinghospital
AT dikshitramk intensivemonitoringofadversedrugreactionsinhospitalizedpatientsoftwomedicalunitsatatertiarycareteachinghospital